Kanker-actueel REOLYSIN, an overview of recent developments and important studies. Update June 18, 2010

Startpagina

Contact | Disclaimer | Sitehulp

Sitemap | Video's

Patiëntenervaringen | Lotgenotencontact

Forum |

Onze Sponsors

Cancer Types

Regular

Complementary

Coaching

Donations

Questions

Cancer News

Addresses

Prevention

Recipes

Artikelen

Virus Injection (REOLYSIN) shows promising results in Phase I study in cancer patients with solid tumors Article posted December 2005

REOLYSIN, a virus that is injected directly into tumors, receives approval from FDA for Phase II trials in prostate cancer and malignant glioma's (brain tumors) after positive results from Phase I trials.

REOLYSIN: Injection virus (REOLYSIN) shows promising results in several studies in cancer patients. Participants sought for Phase II and Phase III studies. Oa in head and neck cancer - melanoma - cancer and sarcomas. Article updated October 17, 2009

REOLYSIN used as a vaccine, achieved good results in soft sarcomas. Thus a small phase II trial. Article posted November 7, 2009

REOLYSIN, an overview of recent developments and important studies. Update June 18, 2010